BRUSSELS (AP) — The European Union’s antitrust body is imposing a fine of 428 million euros ($580 million) on France’s pharmaceutical company Servier and five producers of generic medicines for distorting competition.
The 28-nation bloc’s executive Commission on Wednesday said Servier struck a series of deals with the producers of generic medicines to protect its bestselling blood pressure medicine, Perindopril, from price competition.
Real journalism.Trusted by millions.
Unlimited access to in-depth reporting, expert analysis, and the stories that shape our country.
Subscribe Now
Already a member? Log in
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.